Brief: Poxel Presents Phase 1B Clinical Results For PXl065 And New Preclinical Data For PXL770

Poxel SA

16/11/2020 16:54

Nov 16 (Reuters) - Poxel SA  POXEL.PA :
    * POXEL PRESENTS PHASE 1B CLINICAL RESULTS FOR PXL065 AND
NEW
PRECLINICAL DATA FOR PXL770 AT AASLD THE LIVER MEETING® 2020
    * DATA SUPPORT POTENTIAL UTILITY FOR TREATMENT OF NASH
    * ANALYSIS OF RESULTS FROM PHASE 1B STUDY OF PXL065
(DEUTERIUM-STABILIZED R-PIOGLITAZONE) PREDICTS EFFICACY AT 15 MG
ONCE-DAILY IS EQUIVALENT TO 45 MG ACTOS

Source text for Eikon:  ID:nBw49N05Sa 
Further company coverage:  POXEL.PA 

 (Gdansk Newsroom)
 ((Gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))